Building a Smokeless World

Back
VUSE Premarket Tobacco Product Application Filed for Substantive Review by the FDA
November 26, 2019 4 min read

VUSE Premarket Tobacco Product Application Filed for Substantive Review by the FDA

First-of-its-Kind Filing for VUSE Products WINSTON-SALEM, N.C. – Nov. 27, 2019 – Today, Reynolds American Inc. (“RAI”) announced that the recently-submitted Premarket Tobacco Product Application (“PMTA”) for VUSE vapor products has been filed by the Food and Drug Administration (“FDA”) for substantive scientific review, moving the application one step further through the review process. “This … Continued

Reynolds American Inc. submits Premarket Tobacco Product Application for VUSE products
October 11, 2019 3 min read

Reynolds American Inc. submits Premarket Tobacco Product Application for VUSE products

WINSTON-SALEM, N.C. – Oct. 11, 2019 – Reynolds American Inc. (“Reynolds”) today announced submission of a Premarket Tobacco Product Application (“PMTA”) through one of its subsidiaries to the U.S. Food and Drug Administration (FDA) seeking orders authorizing the marketing of VUSE Electronic Nicotine Delivery Systems (ENDS) products. VUSE products offer a cartridge-based vapor system intended for adult … Continued

R.J. Reynolds Vapor Company Announces VELO – Expanding Emerging Modern Oral Portfolio and Choice for Adult Tobacco Consumers
July 7, 2019 4 min read

R.J. Reynolds Vapor Company Announces VELO – Expanding Emerging Modern Oral Portfolio and Choice for Adult Tobacco Consumers

Company expands the rollout of VELO as part of its innovative Modern Oral portfolio to meet the evolving preferences of today’s adult tobacco consumer with simple, hassle-free, oral nicotine products. Product expansion furthers RJRVC’s commitment to transforming tobacco by leading the charge on responsible innovation in the industry. WINSTON-SALEM, N.C. – July 8, 2019 – R.J. Reynolds … Continued

R.J. Reynolds Tobacco Makes Significant Step on Tobacco Harm Reduction; FDA to Continue its Evaluation on Modified-Risk Claims for Camel Snus
September 13, 2018 3 min read

R.J. Reynolds Tobacco Makes Significant Step on Tobacco Harm Reduction; FDA to Continue its Evaluation on Modified-Risk Claims for Camel Snus

WINSTON-SALEM, N.C. – Sept. 14, 2018 – Today, a scientific advisory committee of the U.S. Food and Drug Administration (FDA) advanced R.J. Reynolds Tobacco Company’s (R.J. Reynolds) efforts to communicate reduced-risk information to consumers regarding its Camel Snus products. The Tobacco Products Scientific Advisory Committee (TPSAC) recognized that the available science supports that switching completely from cigarettes to … Continued

FDA accepts and files modified risk tobacco product applications for Camel Snus
December 17, 2017 3 min read

FDA accepts and files modified risk tobacco product applications for Camel Snus

WINSTON-SALEM, N.C. – December 18, 2017 – Reynolds American Inc. today announced that the U.S. Food and Drug Administration (FDA) accepted, and filed for substantive review, 18 Modified Risk Tobacco Product (MRTP) applications covering 6 styles of Camel Snus. R.J. Reynolds Tobacco Company (RJRT) introduced the premium pouched, smokefree tobacco product in 2006 and markets it nationwide. … Continued

R.J. Reynolds Tobacco Company Submits Modified Risk Tobacco Product Applications For Camel Snus
April 2, 2017 3 min read

R.J. Reynolds Tobacco Company Submits Modified Risk Tobacco Product Applications For Camel Snus

WINSTON-SALEM, N.C. – April 3, 2017 – Reynolds American Inc. (NYSE: RAI) today announced that its R.J. Reynolds Tobacco Company (RJRT) subsidiary has submitted Modified Risk Tobacco Product (MRTP) applications to the U.S. Food and Drug Administration (FDA) covering six styles of Camel Snus, its premium pouched, smokeless tobacco product introduced in 2006 and marketed nationwide. To support … Continued